$TXMD

$1.78 -$0.02 (1.11%) Close

$TXMD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 11.6M shares outstanding

Who owns TXMD?

By type of holder

Institutions 31.7% Insiders 2.8% Everyone else 65.5%

Concentration Top 10 holders own 30.3%

Rubric Capital Management LP 10.3% · Clearline Capital LP 5.5%

Institutional ownership

31.7%

-2.3 pts vs last qtr

Institutional holders

-5 vs last qtr

Net shares bought

−264.1K

by institutions in Q2 2026

New / sold out

4 / 9

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

ADAR1 Capital Management, LLC +133.2K
Citadel Advisors LLC +17.8K

Biggest sellers in Q2 2026

Squadron Capital Management LLC SOLD OUT −420.4K
Susquehanna International Group, LLP SOLD OUT −21.2K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for TherapeuticsMD Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+45.3%

+9.80% a year

Each share's claim on the business

−31.2%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $31.3M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years83% 1–3 years13% Under 1 year4%

Quarterly turnover

8.4%

of institutional shares changed hands

Top 10 managers, median time held

3.5 years

Super Investors

Investment managers reporting TXMD on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
RC Rubric Capital Management LP	1.2M	10.30%	Unchanged	2022	0.0%
Shares held by quarter Peak holding1.2M (Q3'24) Change over 8 quarters0 Share of the company10.300% Rubric Capital Management LP's full portfolio →
CC Clearline Capital LP	635.2K	5.49%	Unchanged	2022	0.1%
Shares held by quarter Peak holding636.6K (Q3'24) Change over 8 quarters−1.4K Share of the company5.490% Clearline Capital LP's full portfolio →

Rubric Capital Management LP

1.2M

% of company

10.30%

Change vs last qtr

Unchanged

Held since

2022

Clearline Capital LP

635.2K

% of company

5.49%

Change vs last qtr

Unchanged

Held since

2022

28 more super investors behind a free account

See every manager holding TherapeuticsMD Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting TXMD on Form N-PORT; together they hold 4.2% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$540K	244.3K	2.11%	0.00%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$242K	109.4K	0.95%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$540K

% of company

2.11%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$242K

% of company

0.95%

% of the fund

0.00%

As of

June 30, 2026

12 more funds behind a free account

See every fund holding TherapeuticsMD Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
TT Thompson Tommy G Insider	124.0K	1.07%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company1.070% Thompson Tommy G's insider activity →
CC Collins Cooper C. Insider	119.7K	1.03%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company1.030% Collins Cooper C.'s insider activity →

Thompson Tommy G

Insider

124.0K

% of company

1.07%

Change vs last qtr

—

Held since

—

Collins Cooper C.

Insider

119.7K

% of company

1.03%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of TherapeuticsMD Inc.

Comments